Top
OR2B11 has not been detected as a mutational cancer driver

OR2B11
Ensembl id ENSG00000177535
Mutated samples
Coding Sequence 72 (1.1%)
Protein Affecting 46 (0.7%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2B11 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 26 12 3.25
Lung adenocarcinoma No 10 9 2.30
Lung squamous cell carcinoma No 11 8 4.60
Uterine corpus endometrioid carcinoma No 4 4 1.74
Small cell lung carcinoma No 3 3 4.35
Colorectal adenocarcinoma No 4 3 1.31
Breast carcinoma No 3 2 0.17
Stomach adenocarcinoma No 2 2 1.24
Serous ovarian adenocarcinoma No 2 1 0.32
Head and neck squamous cell carcinoma No 2 1 0.27
Glioblastoma multiforme No 1 1 0.26
Prostate adenocarcinoma No 2 0 0.00
Bladder carcinoma No 1 0 0.00
Renal clear cell carcinoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence